Clinical Trial Update: A Study of IMC-CS4 in Subjects With Advanced Solid Tumors [Phase 1]

View source ↗

Summary

This is a Phase 1 clinical trial update for IMC-CS4 in adults with advanced solid tumors. The study has completed enrollment and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• IMC-CS4

Snippet

Sponsor: Eli Lilly and Company | Conditions: Neoplasms | Phase 1 | Status: COMPLETED | Results posted: 2024-09-19